Human CSF2RA Protein

<strong>Human CSF2RA Protein</strong>_x000D_ <strong>Catalog number:</strong> B2012047_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1 mg/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> CD116 protein, CDw116 protein, CSF2R protein, GM-CSF-R-alpha protein, GMCSFR protein, GMR protein, SMDP4 protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Suzuki T, Trapnell BC. Pulmonary Alveolar Proteinosis Syndrome Clin Chest Med. 2016 Sep;37(3):431-40._x000D_ 2: Wang H, Zhu H, Zhu W, Xu Y, Wang N, Han B, Song H, Qiao J. Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Turner Syndrome Front Endocrinol (Lausanne). 2020 Mar 6;11:104._x000D_ 3: Huang R, Cao Y, Li H, Hu Z, Zhang H, Zhang L, Su W, Xu Y, Liang L, Melgiri ND, Jiang L, Li X. miR-532-3p-CSF2RA Axis as a Key Regulator of Vulnerable Atherosclerotic Plaque Formation Can J Cardiol. 2020 Nov;36(11):1782-1794._x000D_ 4: Wang Z, Yin W, Zhu L, Li J, Yao Y, Chen F, Sun M, Zhang J, Shen N, Song Y, Chang X. Iron Drives T Helper Cell Pathogenicity by Promoting RNA-Binding Protein PCBP1-Mediated Proinflammatory Cytokine Production Immunity. 2018 Jul 17;49(1):80-92.e7._x000D_ 5: Hetzel M, Suzuki T, Hashtchin AR, Arumugam P, Carey B, Schwabbauer M, Kuhn A, Meyer J, Schambach A, Van Der Loo J, Moritz T, Trapnell BC, Lachmann N. Function and Safety of Lentivirus-Mediated Gene Transfer for CSF2RA-Deficiency Hum Gene Ther Methods. 2017 Dec;28(6):318-329._x000D_ 6: Stanulla M, Dagdan E, Zaliova M, Möricke A, Palmi C, Cazzaniga G, Eckert C, Te Kronnie G, Bourquin JP, Bornhauser B, Koehler R, Bartram CR, Ludwig WD, Bleckmann K, Groeneveld-Krentz S, Schewe D, Junk SV, Hinze L, Klein N, Kratz CP, Biondi A, Borkhardt A, Kulozik A, Muckenthaler MU, Basso G, Valsecchi MG, Izraeli S, Petersen BS, Franke A, Dörge P, Steinemann D, Haas OA, Panzer-Grümayer R, Cavé H, Houlston RS, Cario G, Schrappe M, Zimmermann M; TRANSCALL Consortium; International BFM Study Group. IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia J Clin Oncol. 2018 Apr 20;36(12):1240-1249._x000D_ 7: Allenet B, Escalier D, Garchon HJ. A putative human equivalent of the murine Xlr (X-linked, lymphocyte-regulated) protein Mamm Genome. 1995 Sep;6(9):640-4._x000D_ 8: Rappold G, Willson TA, Henke A, Gough NM. Arrangement and localization of the human GM-CSF receptor alpha chain gene CSF2RA within the X-Y pseudoautosomal region Genomics. 1992 Oct;14(2):455-61._x000D_ 9: Autenshlyus A, Arkhipov S, Mikhailova E, Marinkin I, Arkhipova V, Varaksin N. The Relationship Between Cytokine Production, CSF2RA, and IL1R2 Expression in Mammary Adenocarcinoma, Tumor Histopathological Parameters, and Lymph Node Metastasis Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819883626._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/23933508">10: van Nieuwenhuijze A, Koenders M, Roeleveld D, Sleeman MA, van den Berg W, Wicks IP. GM-CSF as a therapeutic target in inflammatory diseases Mol Immunol. 2013 Dec;56(4):675-82. </a>_x000D_ _x000D_ <strong>Products Related to Human CSF2RA Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>